VF
TCRT icon

Virtu Financial’s Alaunos Therapeutics TCRT Stock Holding History

Virtu Financial’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,544
Closed -$28K – 1867
2024
Q1 		$28K Buy
+1,544
New +$30.9K ﹤0.01% 1123
2022
Q4 		– Sell
-497
Closed -$128K – 2120
2022
Q3 		$128K Buy
+497
New +$144K 0.01% 1019
2022
Q1 		– Sell
-357
Closed -$58K – 2017
2021
Q4 		$58K Sell
357
-40
-10% -$8.79K 0.01% 1305
2021
Q3 		$108K Buy
+397
New +$121K 0.01% 1122
2021
Q2 		– Sell
-467
Closed -$252K – 2062
2021
Q1 		$252K Buy
+467
New +$291K 0.02% 920
2020
Q4 		– Sell
-100
Closed -$38K – 1780
2020
Q3 		$38K Buy
+100
New +$44.2K 0.01% 850
2019
Q4 		– Sell
-164
Closed -$105K – 1834
2019
Q3 		$105K Sell
164
-224
-58% -$178K 0.01% 1083
2019
Q2 		$340K Buy
388
+82
+27% +$56.4K 0.02% 722
2019
Q1 		$177K Sell
306
-128
-29% -$53.5K 0.01% 1037
2018
Q4 		$122K Buy
+434
New +$172K 0.01% 1083
2018
Q3 		– Sell
-88
Closed -$40K – 2180
2018
Q2 		$40K Sell
88
-107
-55% -$67.8K ﹤0.01% 1796
2018
Q1 		$115K Sell
195
-463
-70% -$289K 0.01% 1547
2017
Q4 		$408K Buy
658
+591
+882% +$425K 0.02% 995
2017
Q3 		$62K Buy
+67
New +$59.5K ﹤0.01% 2194

Other funds holding TCRT

MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return

Virtu Financial's TCRT Position: Q2 2024 in Review

Virtu Financial sold out of Alaunos Therapeutics (TCRT) in Q2 2024, closing a stake of 1,544 shares — an estimated $28K sold.

Virtu Financial first reported a position in TCRT in Q3 2017 and held it in 14 quarters. The position peaked at $408K in Q4 2017. 50 funds tracked by Wall St. Rank hold TCRT as of Q2 2024.

  • Virtu Financial reported no remaining Alaunos Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Virtu Financial sold 1,544 Alaunos Therapeutics shares in Q2 2024, an estimated $28K.
  • Virtu Financial first reported a position in Alaunos Therapeutics in Q3 2017 and held it in 14 quarters.
  • Virtu Financial's Alaunos Therapeutics position peaked at $408K in Q4 2017.
  • 50 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q2 2024.

Based on Virtu Financial's 13F filing for Q2 2024, filed 9 Aug 2024.